Search results
UiPath stock downgraded by TD Cowen amid CEO exit and outlook concerns By Investing.com
Investing.com· 3 days agoOn Thursday, TD (TSX:TD) Cowen adjusted its stance on UiPath Inc. (NYSE:PATH) stock, shifting from a...
Dick's Sporting Goods shares target raised by TD Cowen on strong Q1 earnings By Investing.com
Investing.com· 3 days agoOn Thursday, TD (TSX:TD) Cowen maintained a positive stance on Dick's Sporting Goods (NYSE:...
Pure Storage shares target raised by TD Cowen on strong results By Investing.com
Investing.com· 3 days agoOn Thursday, TD (TSX:TD) Cowen showed confidence in Pure Storage (NYSE:PSTG) shares by raising its...
Biohaven shares hold steady with $55 target from TD Cowen By Investing.com
Investing.com· 3 days agoOn Wednesday, TD (TSX:TD) Cowen maintained a Buy rating on Biohaven Pharmaceutical Holding...
TD Cowen Begins Coverage on Fortrea (NASDAQ:FTRE)
ETF DAILY NEWS· 4 days agoEquities researchers at TD Cowen initiated coverage on shares of Fortrea (NASDAQ:FTRE – Get Free Report) in a research note issued to investors on Wednesday, Briefing.com ...
Agilent shares target cut by TD Cowen amid lowered F24 guide By Investing.com
Investing.com· 3 days agoOn Thursday, TD Cowen adjusted its outlook on Agilent Technologies, Inc. (NYSE:A) shares, lowering...
CAVA Group shares target raised by TD Cowen on strong 1Q results By Investing.com
Investing.com· 4 days agoOn Wednesday, TD (TSX:TD) Cowen expressed confidence in CAVA Group Inc (NYSE:CAVA) shares, raising...
TD Cowen reaffirms Yum! Brands stock buy rating due to Taco Bell's strength By Investing.com
Investing.com· 5 days agoBrands (NYSE:YUM) sustained its Buy rating and a price target of $156.00 as reaffirmed by TD...
Ethereum ETF Greenlight Signals Path for More Crypto Investment Funds: TD Cowen
Cryptonews· 7 days agoThe recent approval of Ethereum exchange-traded funds (ETFs) has opened the doors for more crypto...
Insmed PT Raised to $67 at TD Cowen
Investing.com via Yahoo Finance· 4 days agoTD Cowen analysts raised the price target on Insmed (NASDAQ:INSM) to $67.00 (from $45.00) while maintaining a Buy rating. The analysts commented, "We...
